West Pharmaceutical Services, Inc. (WST) Tops Q4 EPS by 4c, Offers FY12 EPS Outlook
Get Alerts WST Hot Sheet
Price: $376.00 -2.52%
EPS Growth %: -21.2%
Financial Fact:
Operating profit: 51.3M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -21.2%
Financial Fact:
Operating profit: 51.3M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.59, $0.04 better than the analyst estimate of $0.55. Revenue for the quarter came in at $295.4 million versus the consensus estimate of $290.05 million.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.37-$2.55, versus the consensus of $2.51.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.37-$2.55, versus the consensus of $2.51.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Union Pacific (UNP) Tops Q1 EPS by 18c
- Tractor Supply (TSCO) Tops Q1 EPS by 12c ; Offers Guidance
- The Shyft Group (SHYF) Tops Q1 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!